Form 8-K - Current report:
SEC Accession No. 0001157523-19-002026
Filing Date
2019-10-02
Accepted
2019-10-02 08:15:54
Documents
12
Period of Report
2019-10-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K a52104578.htm   iXBRL 8-K 41223
  Complete submission text file 0001157523-19-002026.txt   185786

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA teva-20191002.xsd EX-101.SCH 4389
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20191002_lab.xml EX-101.LAB 23692
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20191002_pre.xml EX-101.PRE 16832
9 EXTRACTED XBRL INSTANCE DOCUMENT a52104578_htm.xml XML 4471
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 191130829
SIC: 2834 Pharmaceutical Preparations